# Study of the Excretion of Orally Administered Corticosteroids for the Improval of the Detection of Said Substances in Anti-doping Controls

> **NCT04791345** · PHASE1 · UNKNOWN · sponsor: **Parc de Salut Mar** · enrollment: 50 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Methylprednisone
- **DRUG:** Methylprednisone
- **DRUG:** Deflazacort
- **DRUG:** Dexamethasone
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04791345
- **Lead sponsor:** Parc de Salut Mar
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-26
- **Primary completion:** 2022-02-26
- **Final completion:** 2022-02-26
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04791345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04791345, "Study of the Excretion of Orally Administered Corticosteroids for the Improval of the Detection of Said Substances in Anti-doping Controls". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04791345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*